Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

Historical Holders from Q2 2022 to Q3 2025

Symbol
NERV on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
86,001,722
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,979,675
Holdings value
$4,208,645
% of all portfolios
0%
Number of holders
22
Number of buys
8
Number of sells
-6
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 19.86% +2.8% $35,502,800 +$30,394,980 9,392,275 +595% Federated Hermes, Inc. 22 Dec 2025
Vivo Opportunity Fund Holdings, L.P. 9.99% $32,476,142 8,591,572 Vivo Opportunity Fund Holdings, L.P. 23 Dec 2025
Farallon Capital Partners, L.P. 9.99% $17,160,648 4,539,854 Dapice Joshua J. 22 Dec 2025

Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,979,675 $4,208,645 +$81,860 $2.1 22
2025 Q2 1,944,466 $3,341,879 -$12,369 $1.72 18
2025 Q1 1,951,817 $3,310,087 -$310,831 $1.7 19
2024 Q4 2,085,897 $4,630,050 -$81,975 $2.22 21
2024 Q3 2,118,026 $5,654,665 +$83,536 $2.67 19
2024 Q2 2,086,302 $6,654,936 -$42,908 $3.19 20
2024 Q1 2,099,790 $5,416,495 -$2,569,915 $2.58 20
2023 Q4 2,415,482 $14,854,825 +$68,371 $6.15 19
2023 Q3 2,403,051 $16,580,809 +$303,012 $6.9 19
2023 Q2 2,352,300 $19,044,605 +$5,865,507 $9.14 18
2023 Q1 1,680,901 $2,687,500 -$78,110 $1.6 14
2022 Q4 1,729,786 $2,748,707 -$3,027,635 $1.59 17
2022 Q3 2,028,914 $18,733,000 -$1,898,373 $9.24 23
2022 Q2 2,269,165 $7,508,000 +$7,508,000 $3.31 20